Eurofins Scientific SE
ERFSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10 | $14 | $13 | $21 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $4 | $4 | $3 | $3 |
| Enterprise Value | $13 | $17 | $16 | $24 |
| Revenue | $7 | $7 | $7 | $7 |
| % Growth | 6.7% | -2.9% | -0.1% | – |
| Gross Profit | $5 | $1 | $4 | $5 |
| % Margin | 67.8% | 21.1% | 66.8% | 68% |
| EBITDA | $1 | $1 | $1 | $2 |
| % Margin | 19.7% | 18.7% | 20.2% | 22.9% |
| Net Income | $0 | $0 | $1 | $1 |
| % Margin | 5.8% | 4.8% | 9.1% | 11.6% |
| EPS Diluted | 2.09 | 1.3 | 3.07 | 3.9 |
| % Growth | 60.8% | -57.7% | -21.3% | – |
| Operating Cash Flow | $1 | $1 | $1 | $2 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $1 | $0 | $0 | $1 |